The Bio-based 1,4-Butanediol Market size is estimated at 38.82 kilotons in 2024, and is expected to reach 60.83 kilotons by 2029, growing at a CAGR of 9.40% during the forecast period (2024-2029).
The COVID-19 pandemic affected the bio-based 1,4-butanediol market because of quarantined workforces, general businesses shut down, and disrupted supply chains. During the pandemic, many factories responsible for bio-based 1,4-butanediol production were shut down. The closure of these manufacturing plants dampened bio-based 1,4-butanediol sales. Sections like automobile, electrical and electronics, and textile were temporarily held. However, in the present scenario, the market growth recovered.
The global bio-based 1,4 butanediol market is an oligopoly, where Novamont SpA holds the dominant production capacity share. Some of the noticeable players in the market include Novamont SpA, Shandong Landian Biological Technology, DSM, BASF SE, and Global Bio-chem Technology Group Company Limited (not in a particular order), among others.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook